🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China flag China · Delayed Price · Currency is CNY
41.62
-0.93 (-2.19%)
Nov 20, 2026, 3:04 PM CST

Betta Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Betta Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of ¥58.14. The average 1-year stock price forecast is 39.69% higher than the current stock price, while the lowest is ¥37.23 (-10.55%) and the highest is ¥79.05 (+89.93%).

Price Target: ¥58.14 (+39.69%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price¥37.23¥58.14¥58.14¥79.05
Change-10.55%+39.69%+39.69%+89.93%

Analyst Ratings

The average analyst rating for Betta Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMar '26Apr '26Jun '26Jul '26Aug '26Nov '26
Strong Buy210001
Buy111000
Hold000000
Sell100000
Strong Sell111111
Total532112

Financial Forecast

Revenue This Year
3.94B
from 3.61B
Increased by 9.12%
Revenue Next Year
4.50B
from 3.94B
Increased by 14.33%
EPS This Year
3.14
EPS Next Year
n/a
from 3.14
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingJan 1, 2022Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.25B2.38B2.46B2.89B3.61B3.94B
Revenue Growth
20.08%5.82%3.35%17.74%24.81%9.12%
Gross Profit
2.07B2.11B2.05B2.35B2.87B2.95B
Gross Margin
92.23%88.69%83.53%81.38%79.53%75.00%
Operating Income
348.77M206.96M279.88M476.96M540.45M552.27M
Net Income
383.07M145.42M348.03M402.57M305.33M386.81M
EPS
-----3.14
Forward PE
49.2065.9142.2529.6326.5913.25
Dividend / Share
0.250.070.170.200.150.10
Dividend Growth
-19.36%-72.00%142.86%17.65%-25.00%-36.67%
Free Cash Flow
-----1.91B
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High4.1B
Avg3.9B
Low3.8B

Revenue Growth

Revenue Growth202620272028
High
12.4%
Avg
9.1%
Low
5.8%

EPS Forecast

EPS202620272028
High3.14
Avg3.14
Low3.14

EPS Growth

EPS Growth202620272028
High
221.3%
Avg
221.3%
Low
221.3%